The FBD-500 is a tablet formulation containing 500 mg of Fenbendazole IP in each uncoated tablet; the product available here is supplied in a pack of 10 × 10 tablets and has prescription labeling. Read the information and warnings printed on the original packaging carefully before using the product.
The product packaging states that each uncoated tablet contains 500 mg of Fenbendazole IP, along with the excipients needed for the formulation.
FBD-500 is available as uncoated tablets, and the packaging states that a physician should determine the dosage.
You should not make up your mind about a dose, the length of time to use it, or its medical use based solely on the information given on an ecommerce page. Instead, refer to the original package insert and get advice from a properly qualified healthcare professional.
Follow the instructions for use of the FBD-500 as given with the product and obtain the necessary professional advice.
Do not change the dose, continue treatment longer than directed, repeat a course, or use the tablets for another purpose without consulting an appropriately qualified professional.
It is important to talk to a properly qualified healthcare professional about any relevant medical conditions, allergies, and other medicines or healthcare products before using a prescription product.
If you experience an unexpected or serious reaction, seek prompt medical attention. Online product information is provided for general reference and is not intended to diagnose a condition or establish an individualized treatment regimen.
The regulatory status and permitted uses of Fenbendazole can differ by country and by the specific product involved. The ingredient and strength displayed on this package should not be interpreted as authorization for every proposed medical use.
The page does not present FBD-500 as an FDA-approved medication for use in humans in the United States and makes no assertion that Fenbendazole can be used to treat cancer or any other condition for which the product lacks the necessary regulatory approval.
The package states that the tablets must be kept away from light and moisture and should be stored at a temperature of no more than 30°C. Store the product so that it is out of the children's reach and keep the tablets in their original packaging.
The packaging for the FBD-500 shown has the Healing Pharma branding on it.
The information on this page is general and is based on the product packaging that is available for review; it cannot take the place of professional medical advice, diagnosis, treatment, or the official product documentation. Regulatory requirements and the approved uses may vary from country to country. It is necessary to consult the original package insert and get suitable professional advice before using the product.